MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    Somnolence-Related Events Over Time with Valbenazine Treatment for Chorea Associated with Huntington’s Disease

    E. Furr Stimming, D. Claassen, E. Kayson, J. Goldstein, R. Mehanna, S. Hinton, O. Klepitskaya, H. Zhang, S. Karpuram, D. Thai-Cuarto, G. Liang, D. Haubenberger (Houston, USA)

    Objective: To present somnolence-related events over time from 2 studies of once-daily valbenazine, which is approved for chorea in adults with Huntington’s disease: KINECT®-HD (K-HD,…
  • 2024 International Congress

    Application of Neurophysiology in the Clinical Evaluation of Pediatric and Adolescent Patients with Tremor

    B. Lavenstein, P. Mcgurrrin, F. Vial, E. Akano, S. Attaripour, P. Panyakaew, A. Choi, L. Pesantez-Pacheco, H. Lin, M. Hallett (Bethesda, USA)

    Objective: We explored the utility of noninvasive electrophysiological tremor studies in patients referred  for evaluation by pediatric movement specialists  following their clinical assessment . The…
  • 2024 International Congress

    Daily-life Sensor Based Measurement of Tremor Presence and Amplitude

    K. Ocran, D. Hepp, J. van Hilten, V. Exadaktylos, R. Weijer (Leiden, Netherlands)

    Objective: To evaluate the association between conventional clinical ratings of tremor and one week sensor-based monitoring  of tremor in patients with Parkinson’s disease (PwPD). Background:…
  • 2024 International Congress

    Exploring the non-invasive epigenetic screening test for hereditary dystonia DYT-KMT2B

    N. Sugeno, S. Kumada, H. Kashii, J. Ikezawa, T. Kawarai, T. Nakamura, S. Ishiyama, K. Sato, S. Yoshida, H. Sekiguchi, K. Hamanaka, S. Miyatake, N. Miyake, N. Matsumoto, H. Akagawa, K. Kosaki, H. Yoshihashi, T. Hasegawa, M. Aoki (Sendai, Japan)

    Objective: To explore the altered H3K4me3 levels in non-neural tissue of DYT-KMT2B patients. Background: DYT-KMT2B, also known as DYT28, is a childhood-onset hereditary dystonia caused…
  • 2024 International Congress

    Changes In Glucose Metabolism In Essential Tremor: Within And Beyond The Cerebello-Thalamo-Cortical Circuit

    S. Jonker, J. Dalenberg, D. Peretti, AMM. vd Stouwe, MAJ. Tijssen (Groningen, Netherlands)

    Objective: To investigate differences in brain glucose metabolism between patients with essential tremor and healthy controls using [18F]FDG PET brain imaging. Background: The pathophysiological mechanisms…
  • 2024 International Congress

    Peri-Electrode Edema after Deep Brain Stimulation Implantation – Case Report and Literature Review

    M. Marchiori, L. Packer, R. Pessoa, N. Martins, A. Schilling, M. Brunet (Brazil)

    Objective: To report a case of peri-electrode edema after Deep Brain Stimulation (DBS), and discuss its main aspects. Background: PD is a neurodegenerative condition, and…
  • 2024 International Congress

    Movement Disorders Associated with Infectious Encephalitis in Pediatric Patients

    M. Mnif, H. Benrhouma, T. Benyounes, H. Klaa, Z. Miladi, A. Zioudi, I. Turki, I. Kraoua (Tunis, Tunisia)

    Objective: The objective of our study is to report the clinical and imaging profile of a cohort of pediatric patients with movement disorders (MDs) associated…
  • 2024 International Congress

    Dysfluent Writing Behavior Associates with Reduced Striatal-cerebellar Connectivity in Writer’s Cramp Dystonia

    Z. Simsek, M. Lipp, S. Groves, Z. Huang, M. Fei, J. Voyvodic, C. Petty, M. Lutz, N. Bukhari-Parlakturk (Durham, USA)

    Objective: The primary objective of this study was to identify the brain regions contributing to dysfluent writing behavior in a subtype of dystonia called writer’s…
  • 2024 International Congress

    Repurposing Anti-Gout Medications for the Treatment of Parkinson’s Disease

    R. Hughes, O. Bandmann, L. Ferraiuolo, H. Mortiboys (Sheffield, United Kingdom)

    Objective: To undertake a repurposing drug screen for Parkinson’s disease (PD) and further investigate the mechanism of action of top hits. To assess, in vivo,…
  • 2024 International Congress

    Metabolic Regulators of Mitochondrial DNA Release in Cellular Models of PRKN-linked Parkinson’s Disease

    G. Agyeah, J. Ghelfi, L. Gallucci, A. Rakovic, P. Antony, S. Pereira, A. Grünewald (Belval Esch-sur-Alzette, Luxembourg)

    Objective: Explore metabolic modulation as a disease-modifying target for inflammation in PRKN-PD Background: The release of mitochondrial DNA (mtDNA) is a well-documented phenotype in PRKN-linked…
  • « Previous Page
  • 1
  • …
  • 344
  • 345
  • 346
  • 347
  • 348
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley